← Insider buys
RYTM

Rhythm Pharmaceuticals, Inc. · Healthcare

Chief Technical Officer Joseph Shulman sold $26K of Rhythm Pharmaceuticals, Inc.

Sold$25,612
$27.51Price
931Shares
−25%Stake

What RYTM did after the filing

Prices for RYTM after this filing aren't in yet.

Traded Thu, Feb 9. Filed Tue, Feb 14. Not investment advice.